1. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices;Griffiths;Best Pract Res Clin Rheumatol,2005
2. Clinical trials for lupus — are we there yet?;Merrill;Bull NYU Hosp Jt Dis,2009
3. FDA Labelling Information — Benlysta;US Food and Drug Administration,2011
4. European Medicines Agency;EPAR summary for the public,2011
5. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial;Navarra;Lancet,2011